About Ceribell
Ceribell is a company based in Mountain View (United States) founded in 2014 by Chris Chafe. Ceribell has raised $187.52 million across 4 funding rounds from investors including UCB, LivaNova and RA Capital. The company has 281 employees as of December 31, 2024. Ceribell offers products and services including Point-of-Care EEG, Clarity EEG Portal, and EEG University. Ceribell operates in a competitive market with competitors including Kernel, INBRAIN Neuroelectronics, Mynd Analytics, BioSerenity and BrainScope, among others.
- Headquarter Mountain View, United States
- Employees 281 as on 31 Dec, 2024
- Founders Chris Chafe
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ceribell, Inc.
-
Annual Revenue
$65.44 M (USD)44.71as on Dec 31, 2024
-
Net Profit
-$40.45 M (USD)-37.3as on Dec 31, 2024
-
EBITDA
-$38.57 M (USD)-32.11as on Dec 31, 2024
-
Total Equity Funding
$187.52 M (USD)
in 4 rounds
-
Latest Funding Round
$50 M (USD), Series C
Sep 22, 2022
-
Investors
UCB
& 9 more
-
Employee Count
281
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Ceribell
Ceribell is a publicly listed company on the NASDAQ with ticker symbol CBLL in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Ceribell
Ceribell offers a comprehensive portfolio of products and services, including Point-of-Care EEG, Clarity EEG Portal, and EEG University.
Device for rapid EEG monitoring in critical care settings
Platform for EEG data management and seizure analysis
Online resource for EEG training and guidelines
People of Ceribell
Unlock access to complete
Leadership Team
19 people
Sales and Marketing
16 people
Software Development Team
11 people
Senior Team
10 people
Clinical Team
9 people
Operations Team
7 people
Product Management Team
7 people
Data Analysis and Operations Team
5 people
Unlock access to complete
Funding Insights of Ceribell
Ceribell has successfully raised a total of $187.52M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ceribell
Ceribell has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include UCB, LivaNova and RA Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and hedge fund investments in healthcare are managed.
|
Locked | Locked | Locked | |
|
Private equity firm focused on life science sector
|
Locked | Locked | Locked | |
|
Sector-agnostic VC investment company investing globally
|
Locked | Locked | Locked |
Investor details for Ceribell
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ceribell
Investment portfolio details for Ceribell
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ceribell
Detailed financials for Ceribell
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ceribell Comparisons
Peer comparison for Ceribell
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ceribell
Ceribell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kernel, INBRAIN Neuroelectronics, Mynd Analytics, BioSerenity and BrainScope, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Multimodal brain measurement technology is developed for neuromedicine applications.
|
|
| Locked | Locked | Locked |
AI-based neuroelectronic devices for brain disorder detection are developed.
|
|
| Locked | Locked | Locked |
Provider of reference data and analytic tools for clinicians and researchers in psychiatry.
|
|
| Locked | Locked | Locked |
Provider of smart healthcare solutions for sleep and EEG lab management
|
|
| Locked | Locked | Locked |
Developer of AI-driven EEG platform transforming brain electrical activity into insights
|
Detailed competitors of Ceribell
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ceribell
Complete news archive for Ceribell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ceribell
Ceribell was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Ceribell is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Ceribell is a funded company, having raised a total of $187.52M across 4 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Ceribell is 281.
Annual revenue of Ceribell is $65.44M as on Dec 31, 2024.
Founded in 2014 and based in Mountain View, United States, Ceribell operates in the medical device sector with a focus on neurology diagnostics. Point-of-care EEG systems are developed for seizure detection, including a 10-channel EEG Headband for data recording and a pocket-sized EEG Recorder for real-time signal display, brain activity analysis, and monitoring alerts.
Ceribell's top competitors include INBRAIN Neuroelectronics, BrainScope and Cala Health.
Ceribell offers Point-of-Care EEG, Clarity EEG Portal, and EEG University.
Yes, Ceribell is publicly traded on NASDAQ under the ticker symbol CBLL.
Ceribell has 10 investors. Key investors include UCB, LivaNova, RA Capital, Horizon Tech Finance, and Ally Bridge Group.
The ticker symbol of Ceribell is CBLL on NASDAQ.